15-24% at diabetes doses), vomiting, diarrhea, constipation, and abdominal discomfort, which may be difficult to distinguish from neurogenic bowel dysfunction in MS patients [11] [3] Fatigue : Reported in clinical trials and potentially additive to MS-related fatigue, one of the most disabling MS symptoms Dizziness : May occur due to blood pressure changes or dehydration, overlapping with MS-related balance and vestibular symptoms Weight loss induced by tirzepatidewhile therapeutically beneficial for metabolic healthrequires monitoring in MS patients, as unintentional or excessive weight loss could affect mobility, muscle strength, and overall functional status
Research shows that GLP-1 receptor agonists can indeed reduce muscle mass if proper countermeasures are not in place, though the effect varies significantly between individuals based on genetics, activity level, and nutritional support
Set a daily caffeine limit, opt for decaffeinated options, and be aware of hidden caffeine sources
Mothers, doctors, and pharmacists all face tough decisions when there are no strong guidelines
Victoza (18mg/3ml) dosage starts with 0.6 mg subcutaneous injection per day for at least 1 week